Shelter Pharma launches D3 CURE Capsules

15 Dec 2025 Evaluate

Shelter Pharma has launched D3 CURE Capsules. Shelter has expanded its Nutraceutical portfolio with the launch of D3 Cure Capsules tapping into rapidly growing international market. Primary benefit is the prevention and treatment of vitamin D deficiency. It plays a crucial role in helping the body absorb calcium and phosphorus, which are essential for maintaining overall health.

This launch is part of the Company’s strategy to expand its Nutraceutical portfolio and strengthen its presence in the wellness and preventive healthcare segment. The Company believes that the launch of this product will contribute positively to its growth prospects and reinforce its commitment to providing high-quality, science-backed nutritional solutions. The company continues to focus on building a diverse portfolio of high-quality, accessible wellness products that cater to evolving consumer needs. As it deepens its presence in the Nutraceutical sector, Shelter Pharma is poised to deliver sustained growth, strengthen brand equity, and create long-term value for its customers, partners, and investors alike.

Shelter Pharma is engaged in the business of manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary.

Shelter Pharma Share Price

36.70 0.69 (1.92%)
15-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.25
Dr. Reddys Lab 1280.40
Cipla 1507.25
Zydus Lifesciences 921.25
Lupin 2090.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×